Wall Street Analysts Believe Oric Pharmaceuticals (ORIC) Could Rally 58.43%: Here's is How to Trade

Core Viewpoint - Oric Pharmaceuticals, Inc. (ORIC) has seen a 22% increase in share price over the past four weeks, closing at $13.4, with a mean price target of $21.23 indicating a potential upside of 58.4% according to Wall Street analysts [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $3.9, where the lowest estimate is $15.00 (11.9% increase) and the highest is $25.00 (86.6% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, indicating a more reliable consensus [2][9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about ORIC's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 9.2%, with five estimates moving higher and no negative revisions [12] Zacks Rank and Investment Potential - ORIC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While the consensus price target may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]